Working... Menu

Fosfomycin i.v. for Treatment of Severely Infected Patients (FORTRESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02979951
Recruitment Status : Recruiting
First Posted : December 2, 2016
Last Update Posted : April 15, 2019
Dr. Oestreich + Partner GmbH
Information provided by (Responsible Party):
Infectopharm Arzneimittel GmbH

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2020
  Estimated Study Completion Date : June 2020